Anixa Biosciences Investor Relations Material
Latest events
Status Update
Anixa Biosciences
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Anixa Biosciences Inc
Access all reports
Anixa Biosciences Inc is a biotechnology company focused on developing therapies and vaccines for cancer and infectious diseases. The company pursues programs in immunotherapy, cancer vaccines, and antiviral therapies through research partnerships and internal development. Anixa Biosciences operates in the early-stage biotechnology sector. The company is headquartered in San Jose, California, and its shares are listed on the NASDAQ.
Latest articles
)
David A. Ricks: Eli Lilly's Chairman and CEO
David Ricks built a decades-long career at Eli Lilly, now leading the giant company through a defining moment in its long pharmaceutical history.
3 Jul 2025
)
D. E. Shaw & Co: Inside the Quiet Giant of Quant Finance
A deep dive into D. E. Shaw's evolution from a $28M quant startup to a $65B hedge fund giant, built on research, computing, and quiet consistency.
2 Jul 2025
)
Pershing Square Capital Management: Conviction, Reinvention, and Contrarian Investing
Pershing Square Capital Management has grown into a top-tier hedge fund through reinvention, conviction, and focus on long-term value creation.
2 Jul 2025
Ticker symbol
ANIX
Country
🇺🇸 United States